Yusuke Ochi
Impact in
- Radiation top 10%
- Advanced Radiotherapy Techniques
-
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Radiation 12
- Advanced Radiotherapy Techniques 12
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Co-authors
- Eiji Kumazawa (3 shared papers)Takeshi Jimbo (1 shared paper)Akiko Tohgo (1 shared paper)Yoshinobu Shiose (2 shared papers)Hiroshi Kuga (2 shared papers)Kazuhisa Takahashi (12 shared papers)Hiroaki Ihara (12 shared papers)Motoyasu Kato (8 shared papers)
In The Last Decade
Yusuke Ochi
49 papers receiving 708 citations
Peers
Comparison fields: 5 of 94
- Radiation 63
- Oncology 143
- Pulmonary and Respiratory Medicine 127
- Radiology, Nuclear Medicine and Imaging 84
- Toxicology 12
Countries citing papers authored by Yusuke Ochi
This map shows the geographic impact of Yusuke Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Ochi more than expected).
Fields of papers citing papers by Yusuke Ochi
This network shows the impact of papers produced by Yusuke Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Ochi. The network helps show where Yusuke Ochi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yusuke Ochi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 72 | |
| 2 | 2019 | 62 | |
| 3 | 2018 | 60 | |
| 4 | 2020 | 59 | |
| 5 | Inhibition of experimental metastasis by an alpha-glucosidase inhibitor, 1,6-epi-cyclophellitol. | 1993 | 52 |
| 6 | 2007 | 48 | |
| 7 | 2012 | 43 | |
| 8 | 2004 | 30 | |
| 9 | 2019 | 26 | |
| 10 | 1994 | 23 | |
| 11 | 2021 | 19 | |
| 12 | 2004 | 17 | |
| 13 | 2000 | 16 | |
| 14 | 2022 | 15 | |
| 15 | 2016 | 15 | |
| 16 | 2017 | 15 | |
| 17 | 2020 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 12 | |
| 20 | 2014 | 11 |
About Yusuke Ochi
Yusuke Ochi is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 55 papers that have together received 727 indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer therapeutics and mechanisms (5 papers), Mycobacterium research and diagnosis (4 papers), Lung Cancer Research Studies (3 papers), Frailty in Older Adults (3 papers), Radiation Dose and Imaging (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). The work is most often cited by research in Radiation (63 citations), Oncology (143 citations), Pulmonary and Respiratory Medicine (127 citations), Radiology, Nuclear Medicine and Imaging (84 citations) and Toxicology (12 citations). Yusuke Ochi has collaborated with scholars based in Japan, China and Australia. Frequent co-authors include Eiji Kumazawa, Takeshi Jimbo, Akiko Tohgo, Yoshinobu Shiose, Hiroshi Kuga, Kazuhisa Takahashi, Hiroaki Ihara, Motoyasu Kato, Hironobu Iinuma and Fumiyoshi Yamashita. Their work appears in journals such as Scientific Reports, Physica Medica, Journal of Applied Clinical Medical Physics, International Journal of Radiation Oncology*Biology*Physics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.